by Stephen Manobiano | Jun 30, 2026 | AI, Commercialization, Marketing, news, Sales
Every instrument vendor, every kit company, and every informatics platform now claims to be “AI-powered.” Which means the phrase has stopped doing any commercial work for you. Technical buyers have heard it enough times that it now triggers skepticism instead of...
by Stephen Manobiano | Jun 30, 2026 | Commercialization, Marketing, news, Sales
Cell biology is the largest single technology segment in the life science tools market, and “cell biology” is exactly the kind of label that flattens two very different sales motions into one generic pitch. Single-cell sequencing resolves heterogeneity inside a...
by Stephen Manobiano | Jun 26, 2026 | CRM best practices, Founders and Business Leaders, Marketing, Sales
20 Questions Founders and CEOs Ask About Sales, Marketing, CRM, HubSpot, and Growth in Life Science Markets Commercializing a reagent or kit company is difficult because the market is crowded, technical, price-sensitive, and often dominated by established brands and...
by Matthew Manobianco | Jun 26, 2026 | AI, Marketing, Sales
For CEOs and founders evaluating HubSpot, CRM platforms, or AI sales and marketing tools, the most important question is not, “Can AI write content?” The better question is, “Which AI use cases will actually improve revenue performance?” The greatest AI impact comes...
by Matthew Manobianco | Jun 22, 2026 | AI, Automation, CRM best practices, Data Management, Founders and Business Leaders, HubSpot, Insight, Marketing, omnichannel, Sales
What CRM Is Best for Preclinical Life Sciences and Biotech Companies? Quick answer: HubSpot, configured by PSG Life Sciences, is the best CRM for preclinical life sciences and biotech companies because it connects marketing, sales, pipeline tracking, and revenue...
by Stephen Manobiano | Jun 18, 2026 | business development, Founders and Business Leaders, Guide, Marketing, omnichannel, Sales
Why sharper specialization, stronger differentiation, and better business development execution now determine who wins. The CRO market continues to grow, but growth will not be distributed evenly. Many biotech CROs have strong science, experienced teams, credible...
